AUS
NZ
UK
CA
USA
IND
Healthcare
Hain Celestial Sees Sales Drop in FY 2024, but Profit Margins Improve Amid Cost Management Efforts
August 27, 2024 10:47 PM PDT| By Team Kalkine MediaHain Celestial Group (Nasdaq: HAIN), a prominent global health and wellness company known for its commitment to promoting healthier living through its better-for-you brands, has announced its financial results for the fourth quarter and fiscal year e...
Here’s Zimmer Biomet Debt Usage
August 27, 2024 12:25 PM PDT| By Team Kalkine MediaZimmer Biomet Holdings, a major entity in the,healthcare sector,, has recently attracted attention for its management of debt. Traded under the ticker ZBH, the company’s approach to utilizing debt is under scrutiny, particularly regarding how it impa...
Mettler-Toledo International's Recent Performance: A Healthcare Sector Review
August 27, 2024 12:21 PM PDT| By Team Kalkine MediaMettler-Toledo International Inc., a key player in the,Healthcare sector,, has recently attracted attention due to its performance trends. Traded under the ticker MTD, the company’s market position and operational challenges are under review, reflect...
Industry Veteran Joins Pearsanta Inc. as President
August 26, 2024 11:52 AM PDT| By Team Kalkine MediaHeadlines,Pearsanta Inc. Appoints New President,Christopher Mitton Brings Decades of Expertise to Pearsanta,Aditxt’s Subsidiary Accelerates Precision Health with New Leadership,Aditxt,(NASDAQ:ADTX),, a platform dedicated to advancing health innovatio...
_08_26_2024_21_05_19_715874.jpg)
Medtronic Achieves Key Milestones, Strengthening Market Position
August 26, 2024 12:00 AM PDT| By Team Kalkine MediaIn the,healthcare sector,, Medtronic has announced recent developments that have garnered attention from the market. The company's latest updates highlight significant progress and improvements in its business operations. These advancements are contr...
This Undervalued Stock Could Compete with Eli Lilly for $1 Trillion Valuation
August 22, 2024 11:17 PM PDT| By Team Kalkine MediaEli Lilly is gaining significant attention as its market capitalization approaches $1 trillion, driven largely by optimism surrounding its anti-obesity drugs. This surge in interest may overshadow other pharmaceutical companies creating opportunities...
Zepp Health Cuts Losses, Embraces AI Innovation
August 22, 2024 10:41 AM PDT| By Team Kalkine MediaHeadlines,Zepp Health Boosts Margins with AI and New Tech,Zepp Health's Gross Margins Hit Record High,Zepp Health Plans Exciting Product Launches and Tech Upgrades,Zepp Health Corporation,(NYSE:ZEPP),revealed its second-quarter 2024 results, showing...
Comparing Merck and AbbVie: A Detailed Look
August 22, 2024 01:03 AM PDT| By Team Kalkine MediaHeadlines,Merck Outpaces AbbVie in Revenue Growth,Merck's Superior Profitability and Stability in Pharma,Merck,(NYSE:MRK),has shown strong gains, with its stock price increasing by 65% from early 2021 to around $115 today. However, AbbVie has outperf...
Eli Lilly's Strong Q2 Performance: What's Ahead?
August 14, 2024 08:40 AM PDT| By Team Kalkine MediaHeadlines,Solid Q2 Results: Eli Lilly surpassed expectations with $11.3 billion in revenue and adjusted earnings of $3.92 per share, prompting a 15% rise in its stock price.,Exceptional Performance: The stock has seen a 455% increase since January 20...
2 Biotech Companies to Monitor in August 2024
August 14, 2024 08:10 AM PDT| By Team Kalkine MediaHeadlines,The biotech sector focuses on innovative medical treatments using biological processes, offering substantial growth if successful.,Biotech companies, like Regeneron and Vertex Pharmaceuticals, work on developing drugs and therapies for seri...
Carlyle Group to Acquire Baxter's Kidney-Care Unit Vantive for $3.8 Billion
August 13, 2024 07:40 AM PDT| By Team Kalkine MediaCarlyle Group (NASDAQ:CG),has agreed to purchase Baxter International's kidney-care unit, Vantive, for $3.8 billion. The acquisition, announced on Tuesday, is part of Baxter's strategy to reduce its substantial debt and streamline operations followin...
Novo Nordisk Faces Triple Setback: What Does This Mean for Its Future?
August 13, 2024 12:00 AM PDT| By Team Kalkine MediaHeadlines,Novo Nordisk has encountered three significant challenges recently, affecting its research and regulatory submissions.,The company halted a clinical trial for a MASH treatment, received regulatory pushback on its type 1 diabetes therapy, an...
Anteris Technologies Pursues Nasdaq Listing and US IPO Through Re-Domiciliation
August 13, 2024 12:00 AM PDT| By Team Kalkine MediaHeadlines,Anteris Technologies is planning to relocate its headquarters to the US and relist on the Nasdaq, with a secondary listing on the ASX and an initial public offering (IPO) aimed at raising between US$75 million and US$100 million by the end...
Cardinal Health’s Q4 Earnings Preview: What to Expect and How to Optimize Dividend Returns
August 12, 2024 12:00 AM PDT| By Team Kalkine MediaHeadlines,Cardinal Health is expected to release its Q4 earnings on August 14, with anticipated growth in earnings per share and revenue.,The company has a dividend yield of 2.01%, providing regular payouts to shareholders.,The number of shares neede...
Eli Lilly vs. Johnson & Johnson: Two Pharma and Healthcare Stocks with Global Reach
August 09, 2024 04:48 AM PDT| By Team Kalkine MediaEli Lilly (NYSE:LLY),and,Johnson & Johnson (NYSE:JNJ),are two of the most prominent players in the pharmaceutical and healthcare industries. Both companies are renowned for their extensive product portfolios and global reach, but they are navigating...
Why Eli Lilly's Stock Dropped 20% Last Month
August 08, 2024 09:28 AM PDT| By Team Kalkine MediaHeadlines,Eli Lilly's stock fell 20% in July after Roche announced positive clinical trial results for a weight loss drug.,The competitive landscape in obesity treatments is intensifying, potentially impacting Lilly's market share.,Despite its curren...
CVS Health Struggles with Medicare Business, Cuts Earnings Forecast and Announces Major Cost-Cutting Plan
August 07, 2024 09:09 AM PDT| By Team Kalkine MediaCVS Health (NYSE:CVS) reported continued difficulties in its Medicare business for the second quarter, leading to another reduction in its full-year earnings outlook. The company also unveiled a $2 billion cost-cutting initiative and announced the de...
Bayer's Second-Quarter Loss Misses Expectations Amid Agricultural Market Challenges
August 06, 2024 07:00 AM PDT| By Team Kalkine MediaBayer AG (BAYRY), the German pharmaceutical and agricultural giant, reported a significant net loss for the second quarter, falling short of analysts' expectations due to a challenging agricultural market. The company posted a net loss of €34 million...
Can Recursion Pharmaceuticals Lead to Wealth Creation?
August 06, 2024 12:00 AM PDT| By Team Kalkine MediaHeadlines,Current Status and Pipeline:,Recursion Pharmaceuticals is a young biotech firm with a market cap of $2.2 billion and no marketed products. It relies on collaborations for revenue and has several clinical programs in its pipeline, including...
Top 9 Health Care Stocks Making Waves in August 2024
August 05, 2024 12:00 AM PDT| By Team Kalkine MediaHeadlines,Top Contenders:,Discover the nine standout health care stocks from the,S&P 500,, showcasing their impressive performance over the past year.,Health Care Sectors Explored:,Dive into the different health care sectors, including biotechnology,...
